2Lucky AW,Grote GD,Williams JL,et al.Effect of desonide ointment,0.05%,on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis.Cutis,1997,59:151-153.
3Freeman S,Howard A,Foley P,et al.Efficacy,cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis.Australas J Dermatol,2002,43:186-189.
4Frost P,Horwitz SN.Clinical comparison of alclometasone dipropionate and desonide ointments (0.05%) in the management of psoriasis.J Int Med Res,1982,10:375-378.
5Jorizzo J,Levy M,Lucky A,et al.Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients.J Am Acad Dermatol,1995,33:74-77.
4Ashcroft DM, Chen LC, Garside R. Topical pimecrolimus for eczema[J]. Coehrane Database Syst Rev, 2007(4): CD005500.
5Stege H. Ultraviolet therapy in patients with chronic hand eczema[J]. Hantarzt, 2008, 59(9): 696-702.
6Boyle ILl, Bath-Hextall F J, Leonardi-Bee J, et al. Probiotics for the treatment of eczema: a systematic review[J]. Clin Exp Allergy, 2009, 39(8): 1117-1127.
7Boyle RJ, Both-Hextall F J, Leonardi-Bee J, et al. Probiotics for treating eczema[J]. Cochrane Database Syst Rev, 2008, 8(4): CD006135.
8Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, et al. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review[J]. Br J Dermatol, 2010, 163(1): 12-26.
9Wienert V, Heusinger JH. Local treatment of hemorrhoidal disease Wienert V, Heusinger JI-I. Local treatment of hemorrhoidal disease and perianal eczema-Meta-analysis of the efficacy and safety of an Escherichia coil culture suspension alone or in combination with hydrocortisone[J]. Arzneimittelforschung, 2002, 52(7): 515-523.
10Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema - a systematic review and recta- analysis[J]. J Eur Acad Dcrmatol Venereol, 2007, 21 (5): 606-619.
